ESR1 and breast cancer: We used both an early (treatment-naive; early BC) and a metastatic ER+ PDX tumor that both maintain biological characteristics (such as the expression of ER and estrogen dependence) of the patient primary tumor from which they were derived (Figures S1D and S1E).